Direvo has a stable and long term investor base that has repeatedly demonstrated its confidence in the company.


Current investors include:

TVM V Life Science Ventures GmbH & Co. KG, Munich

NRW.Bank Venture Fonds GmbH & Co. KG, Düsseldorf

Sparkasse KölnBonn, Cologne

Mulligan BioCapital, Hamburg

Danisco Venture ApS, Copenhagen

and several private investors.

Latest News

Direvo enzymes improve ethanol industry margins

» Read more